Main Strategies of Plant Expression System Glycoengineering for Producing Humanized Recombinant Pharmaceutical Proteins
- 作者: Rozov S.1,2, Permyakova N.1, Deineko E.1,3
-
隶属关系:
- Federal Research Center Institute of Cytology and Genetics
- Novosibirsk State University
- National Tomsk State University
- 期: 卷 83, 编号 3 (2018)
- 页面: 215-232
- 栏目: Review
- URL: https://journals.rcsi.science/0006-2979/article/view/151610
- DOI: https://doi.org/10.1134/S0006297918030033
- ID: 151610
如何引用文章
详细
Most the pharmaceutical proteins are derived not from their natural sources, rather their recombinant analogs are synthesized in various expression systems. Plant expression systems, unlike mammalian cell cultures, combine simplicity and low cost of procaryotic systems and the ability for posttranslational modifications inherent in eucaryotes. More than 50% of all human proteins and more than 40% of the currently used pharmaceutical proteins are glycosylated, that is, they are glycoproteins, and their biological activity, pharmacodynamics, and immunogenicity depend on the correct glycosylation pattern. This review examines in detail the similarities and differences between N- and O–glycosylation in plant and mammalian cells, as well as the effect of plant glycans on the activity, pharmacokinetics, immunity, and intensity of biosynthesis of pharmaceutical proteins. The main current strategies of glycoengineering of plant expression systems aimed at obtaining fully humanized proteins for pharmaceutical application are summarized.
作者简介
S. Rozov
Federal Research Center Institute of Cytology and Genetics; Novosibirsk State University
编辑信件的主要联系方式.
Email: rozov@bionet.nsc.ru
俄罗斯联邦, Novosibirsk, 630090; Novosibirsk, 630090
N. Permyakova
Federal Research Center Institute of Cytology and Genetics
Email: rozov@bionet.nsc.ru
俄罗斯联邦, Novosibirsk, 630090
E. Deineko
Federal Research Center Institute of Cytology and Genetics; National Tomsk State University
Email: rozov@bionet.nsc.ru
俄罗斯联邦, Novosibirsk, 630090; Tomsk, 634050